CIK 0001579428
- Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454241907
- Phone
- +1 212-332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Pizzie Nick Chief Financial Officer | Option exercise 10b5-1 | +33,000 | $3.50 | $116K | 75,867 |
| 2026-06-09 | Pizzie Nick Chief Financial Officer | Sale 10b5-1 | −33,000 | $240.09 | $7.9M | 42,867 |
| 2026-06-09 | Pizzie Nick Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −33,000 | 72,000 | ||
| 2026-04-21 | Pizzie Nick Chief Financial Officer | Grant or award · Performance Stock Units | +8,188 | 8,188 | ||
| 2026-02-26 | Pizzie Nick Chief Financial Officer | Grant or award · Restricted Stock Units | +18,570 | 18,570 | ||
| 2026-01-22 | Pizzie Nick Chief Financial Officer | Option exercise 10b5-1 | +12,000 | $3.50 | $42K | 54,588 |
| 2026-01-22 | Pizzie Nick Chief Financial Officer | Sale 10b5-1 | −12,000 | $187.92 | $2.3M | 42,588 |
| 2026-01-22 | Pizzie Nick Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | 105,000 | ||
| 2025-02-24 | Pizzie Nick Chief Financial Officer | Grant or award · Performance Stock Units | +9,423 | 9,423 | ||
| 2025-02-21 | Pizzie Nick Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +9,516 | 9,516 | ||
| 2025-02-21 | Pizzie Nick Chief Financial Officer | Grant or award · Restricted Stock Units | +9,423 | 9,423 | ||
| 2025-02-14 | Pizzie Nick Chief Financial Officer | Option exercise 10b5-1 | +3,000 | $3.50 | $11K | 45,187 |
| 2025-02-14 | Pizzie Nick Chief Financial Officer | Sale 10b5-1 | −3,000 | $131.07 | $393K | 42,187 |
| 2025-02-14 | Pizzie Nick Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,000 | $3.50 | $11K | 0 |
| 2025-02-13 | Pizzie Nick Chief Financial Officer | Option exercise 10b5-1 | +12,000 | $3.50 | $42K | 54,187 |
| 2025-02-13 | Pizzie Nick Chief Financial Officer | Sale 10b5-1 | −12,000 | $129.86 | $1.6M | 42,187 |
| 2025-02-13 | Pizzie Nick Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | $3.50 | $42K | 0 |
| 2024-02-27 | Pizzie Nick CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +28,722 | 28,722 | ||
| 2024-02-27 | Pizzie Nick CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +15,774 | 15,774 | ||
| 2023-03-02 | Pizzie Nick CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +36,246 | 36,246 |
Page 1 of 3 · 44 trades